Executive Spotlight: Kristin Dietzler, VP and General Manager of Nursing Care, Covidien
- Thu, 7/22/10 - 12:47pm
- 0 Comments
- 1444 reads
Kristin Dietzler, VP and General Manager of Nursing Care at Covidien, offers in depth insight into the types of priorities and operations that are needed for Covidien’s wound care business to continually develop and satisfy customers.
Q: Please describe your work experiences that prepared you for your current position at Covidien:
A: For the last 16 years I have had the opportunity to work in a variety of roles for different businesses within Covidien. Throughout this time I have been exposed to different markets and customers and have witnessed the ever-changing dynamics of healthcare.
Q: What should our readers know first and foremost about Covidien?
A: Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes, and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals, and Medical Supplies. With 2009 revenue of $10.7 billion, Covidien has 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries.
Q:How were you first introduced to the arena of wound care and why do you enjoy this vocation?
A: I was first introduced to wound care when I began as a sales representative for Covidien 16 years ago and would call on burn units in hospitals. When I witnessed the pain and agony of patients who were suffering from severe burns, I gained an appreciation for what Covidien’s wound care products can do for patients and why high quality, high-performing products matter.
Q: Please expand on how Covidien values its strong international presence:
A: More than 40% of Covidien’s total revenue comes from outside of the US; our products are sold in over 140 countries. We see great opportunities for growth outside of the US particularly in emerging markets. We also work with clinicians from around the world to better understand their needs as well as the needs of their patients. Our collaboration with medical professionals helps us develop innovative healthcare products to improve patient outcomes.
Q:What are some of the company’s biggest accomplishments in wound care thus far? What are some of your key wound care products that clearly distinguish your brand?







